Third-Party Manufacturing vs PCD Franchise: Which One Should You Start?
Direct answer: start with a PCD franchise if you want low risk and a small budget. Choose third-party manufacturing if you already have distribution and want your own brand and a higher margin.
The two models differ mainly in money and control. Pushkar Pharma's guide states these figures:
PCD Franchise | Third-Party Manufacturing | |
Starting investment | ₹10,000–50,000 initial stock | ₹1.5–5 lakh per batch |
Minimum order | 10–20 boxes | 500–1,000 boxes per batch |
Brand | Parent company's brand | Your own brand name |
Territory | Exclusive district-level rights | No regional monopoly |
Margin | 20%–30% | 40%–60% |
Here is a simple example. A medical representative with ₹30,000 and a drug licence should choose a PCD franchise. The stock is small, the company's brand is already set, and the territory is protected. A distributor who already supplies chemists in several districts should choose third-party manufacturing, because a batch of their own brand earns a higher margin across all of them.
Both models need a wholesale drug licence and GST registration. In third-party manufacturing, you also handle your own promotion, and the page cites a first batch of about 30–45 days.
Pushkar Pharma, based in Kala Amb, Himachal Pradesh, makes sterile injectables, ophthalmic formulations, ear drops, nasal drops and ointments, and offers third-party manufacturing. Ask for the licence and certificates behind any claim, and get the cost in writing.
Comments